PATENT CLAIM ANALYSIS

Application Number: 15962814
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "359000"]

Abstract:
The invention relates to compounds which are mGlu2/3 negative allosteric modulators for use in the treatment of intellectual disabilities. In another aspect, the invention relates to a pharmaceutical composition for use in the treatment of intellectual disabilities comprising a compound according to the invention and a pharmaceutically acceptable carrier.

Claim (Index 3):
A mGlu2/3 negative allosteric modulator according to  claim 1  selected from a compound of formula (I) and formula (II), wherein\n E and J are N, G is C, L is N and M is CH; \n A is pyridin-2-yl; \n B is pyridinyl, \n C is phenyl substituted by SO 2 NH 2 ; \n R 1  is CF 3 ; \n R 2  is H; \n R 3  is CF 3 ; \n R 4  is CH 3 ; \n R 5  is CF 3 ; \n R 6  is H; \n R 7  i s H; \n or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.52941
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12053648', '13178531', '12551625', '11726575', '12394083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.746822933446496
- 35 USC 102 Novelty (BERT): 0.5051073226879579
- Combined Prediction Score: 0.7226513723706421
- Mean Citation Score: 237.48939600000003
- Max Citation Score: 243.01498
- Similarity Product: 180.1458282052052

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test